[Cardiovascular pharmacotherapy and coronary revascularization in end-stage renal failure]
- PMID: 31468075
- DOI: 10.1007/s00059-019-04846-6
[Cardiovascular pharmacotherapy and coronary revascularization in end-stage renal failure]
Abstract
There is a close physiological relationship between the kidneys and the heart. Cardiovascular diseases are the most prevalent cause of death in patients with chronic kidney disease (CKD), whereas CKD may directly accelerate the progression of cardiovascular diseases and is considered to be a cardiovascular risk factor. In patients with mild CKD, i.e. an estimated glomerular filtration rate (eGFR) >60 ml/min/1.73 m2, treatment of coronary artery disease and chronic heart failure is not essentially different from patients with preserved renal function; however, as most pivotal trials have systematically excluded patients with advanced renal failure, many treatment recommendations in this patient group are based on observational studies, post hoc subgroup analyses and meta-analyses or pathophysiological considerations, which are not supported by controlled studies. Therefore, prospective randomized studies on the management of heart failure and coronary artery disease are needed, which should specifically focus on the growing number of patients with advanced renal functional impairment.
Keywords: Cardiorenal syndrome; Cardiovascular diseases; Chronic renal insufficiency; Coronary disease; Heart failure.
Similar articles
-
Impact of renal function impairment assessed by CKDEPI estimated glomerular filtration rate on early and late outcomes after coronary artery bypass grafting.Int J Cardiol. 2017 Jan 15;227:778-787. doi: 10.1016/j.ijcard.2016.10.059. Epub 2016 Oct 24. Int J Cardiol. 2017. PMID: 27843046
-
Glomerular filtration rate, cardiorenal end points, and all-cause mortality in type 2 diabetic patients.Diabetes Care. 2006 Sep;29(9):2046-52. doi: 10.2337/dc06-0248. Diabetes Care. 2006. PMID: 16936151
-
Kidney function modifies the selection of treatment strategies and long-term survival in stable ischaemic heart disease: insights from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) registry.Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):274-282. doi: 10.1093/ehjqcco/qcx042. Eur Heart J Qual Care Clin Outcomes. 2018. PMID: 29106471
-
Revascularization options in patients with chronic kidney disease.Tex Heart Inst J. 2010;37(1):9-18. Tex Heart Inst J. 2010. PMID: 20200622 Free PMC article. Review.
-
Cardiovascular disease in chronic kidney disease in 2015.Curr Opin Nephrol Hypertens. 2016 May;25(3):203-7. doi: 10.1097/MNH.0000000000000213. Curr Opin Nephrol Hypertens. 2016. PMID: 27023835 Review.
Cited by
-
Effects of Systematic Diet Education Combined with Multidisciplinary Nursing on Nutritional Status and Calcium and Phosphorus Metabolism in Patients with Diabetic Kidney Disease in Uremic Phase after Treatment with Alogliptin.J Healthc Eng. 2022 Mar 15;2022:1120242. doi: 10.1155/2022/1120242. eCollection 2022. J Healthc Eng. 2022. PMID: 35340239 Free PMC article. Clinical Trial.
-
[Current aspects of heart-kidney interactions : Summary of important clinical studies from 2020].Herz. 2022 Apr;47(2):150-157. doi: 10.1007/s00059-021-05043-0. Epub 2021 Jun 9. Herz. 2022. PMID: 34106300 Free PMC article. Review. German.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous